← Back to Search

Technology-Based Messaging for Increasing COVID-19 Vaccine Uptake

N/A

Recruiting

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be age 18 years or older, able to provide informed consent, able to read and understand English or Spanish

Be older than 18 years old

Must not have

Individuals who are not yet adults (infants, children, teenagers)

Adults unable to consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trialwill increase COVID-19 vaccine uptake among PWID by exploring their hesitancy and identifying ways to reduce barriers to vaccination.

Who is the study for?

This trial is for adults over 18 who use injection drugs and haven't been vaccinated against COVID-19. They must understand English or Spanish, be able to consent, and not have been vaccinated before. Pregnant women, those unable to consent, minors, and prisoners are excluded.

What is being tested?

The study tests whether technology-based messaging with a video can increase COVID-19 vaccine uptake among people who inject drugs compared to messaging without a video.

What are the potential side effects?

Since the interventions involve informational messages with or without videos rather than medical treatments or vaccines themselves, there are no direct side effects associated with this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older, can consent to treatment, and understand English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under the age of 18.

Select...

I am unable to give consent for medical procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Vaccination series completion

Vaccination uptake at baseline

Vaccination uptake at follow-up

Secondary study objectives

SARS-CoV-2 literacy at baseline

SARS-CoV-2 literacy at follow-up

Secondary

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Video text conditionExperimental Treatment1 Intervention

Participants in the video text condition will receive the text messages designed to increase vaccination among our sample, along with links to iteratively developed intervention videos

Group II: No video conditionExperimental Treatment1 Intervention

Participants in the no video condition will receive weekly text messages designed to increase vaccination among our sample.

0 / 3Eligibility criteria met